Overview

A Study of the Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, From Phase B, With Multiple Sclerosis (MS)

Status:
Completed

Trial end date:
2009-01-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether Sativex® versus Placebo is effective in the relief of symptoms of spasticity in subjects with multiple sclerosis, who have been identified as having a capacity to respond to Sativex.

Phase:

Phase 3

Details

Lead Sponsor:

GW Pharmaceuticals Ltd.

Treatments:

Nabiximols